Skip to Main Content

Back to Events

The Noreen O'Neill Melanoma Research Virtual Symposium: Understanding Melanoma Progression and Therapy Resistance

Symposium
Wednesday, Jun. 16, 2021 12:00 p.m. to 4:00 p.m.

Melanoma is an aggressive, highly heterogeneous disease. Targeted therapies and immunotherapies have brought a substantial improvement in overall patient survival, but long-term success of these treatments is hindered by therapy resistance. While a number of molecular mechanisms underlying resistance and approaches to bypass it are under investigation, many challenges remain ahead. During the symposium, you will hear about new models and strategies to investigate key aspects of melanoma progression and metastasis and novel approaches to overcome therapy resistance.

Agenda details to come. 

*Symposium held via GoToWebinar.

Register Today

David Adams_final

David Adams, Ph.D.
Wellcome Sanger Institute

View bio.

Corine Bertolotto, Ph.D.

Corine Bertolotto, Ph.D.
University of Nice Sophia Antipolis

View bio.

Marianne Berwick, Ph.D.

Marianne Berwick, Ph.D.
University of New Mexico

View bio.

Keith Flaherty, M.D.

Keith Flaherty, M.D.
Massachusetts General Hospital

View bio.

Thomas Graeber, Ph.D.

Thomas Graeber, Ph.D.
University of California, Los Angeles

View bio. 

Michal Lotem, M.D.

Michal Lotem, M.D.
The Concern Foundation Laboratories at The Lautenberg Center for Immunology and Cancer Research

View bio. 

Yardena Samuels, Ph.D.

Yardena Samuels, Ph.D.
Weizmann Institute of Science

View bio. 

Jedd D. Wolchok, M.D., Ph.D.

Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center

View bio.